Autoimmune Life Blog

With a newly awarded $4 million grant from The Leona M. and Harry B. Helmsley Charitable Trust, BRI and SCRI will now focus on using their novel approach to generate an engineered T cell product that can be used in a future first-in-human clinical trial.

Over the past year, BRI has been working toward a new vision of creating a healthy immune system for everyone.

We’re all hearing that people with underlying conditions and immune deficiencies are more susceptible to COVID-19. It’s natural for people with autoimmune disease to wonder what this means for them.

We recently kicked off a potentially game-changing partnership with the new Allen Institute for Immunology. Fueled by a $125 million gift from the late Paul G. Allen, this partnership aims to learn more about how the immune system works from health to disease.

In April 2017, Steve Gordon and his daughter, Callie Triller, hiked to Machu Picchu in Peru. Seven months later, Steve started experiencing severe joint pain and learned he had rheumatoid arthritis (RA).

Immunotherapy is one of the biggest medical breakthroughs in decades: It can cure some cancers by telling the immune system to find and kill cancer cells.

BRI is inviting Seattle-area adults to participate in the Sound Life Project, a groundbreaking research study to build a baseline of knowledge over time about the human immune system to better understand disease.

BRI has made game-changing discoveries and significantly expanded our research and funding in recent years.

It might seem unlikely for scientists at Benaroya Research Institute at Virginia Mason (BRI), a research institute focused on causes and cures for autoimmune disease, to study cancer. Scientists like Dr.

Lori Carter is a national sales manager, a personal health coach, a wife and a mom. Her life was moving a million miles an hour before she was diagnosed with Systemic Lupus Erythematosus (SLE), a chronic, systemic autoimmune disease, in April of 2013.